Matriptase: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
Michal Harel (talk | contribs)
No edit summary
Line 11: Line 11:
== Structural highlights ==
== Structural highlights ==
ST14 active site has the conformation of a typical serine protease like trypsin or chymotrypsin with the <scene name='59/595760/Cv/5'>Ser-His-Asp catalytic triad</scene> and <scene name='59/595760/Cv/6'>Gly-Ser oxyanion hole</scene>.  The <scene name='59/595760/Cv/7'>inhibitor benzamidine blocks the catalytic triad</scene><ref>PMID:11696548</ref>. Water molecules shown as red spheres.
ST14 active site has the conformation of a typical serine protease like trypsin or chymotrypsin with the <scene name='59/595760/Cv/5'>Ser-His-Asp catalytic triad</scene> and <scene name='59/595760/Cv/6'>Gly-Ser oxyanion hole</scene>.  The <scene name='59/595760/Cv/7'>inhibitor benzamidine blocks the catalytic triad</scene><ref>PMID:11696548</ref>. Water molecules shown as red spheres.
== 3D Structures of matriptase ==
[[Matriptase 3D structures]]
</StructureSection>
</StructureSection>


Line 20: Line 24:
*'''matriptase'''
*'''matriptase'''


**[[4is5]] – hST14 catalytic domain - human<br />
**[[4is5]], [[5lyo]] – hST14 catalytic domain - human<br />


*Matriptase complex with small molecule inhibitor
*Matriptase complex with small molecule inhibitor
Line 29: Line 33:
**[[4o97]], [[4o9v]] – hST14 catalytic domain + benzamidine derivative + tetrapeptide<br />
**[[4o97]], [[4o9v]] – hST14 catalytic domain + benzamidine derivative + tetrapeptide<br />
**[[3ncl]] – hST14 catalytic domain (mutant) + benzamidine derivative<br />
**[[3ncl]] – hST14 catalytic domain (mutant) + benzamidine derivative<br />
**[[2gv7]], [[4jz1]], [[4jzi]], [[4jyt]] – hST14 catalytic domain + inhibitor<br />
**[[2gv7]], [[4jz1]], [[4jzi]], [[4jyt]], [[4r0i]] – hST14 catalytic domain + inhibitor<br />
**[[6n4t]] – hST14 catalytic domain + benzothiazole derivative<br />


*Matriptase complex with polypeptide inhibitor
*Matriptase complex with polypeptide inhibitor